Cargando…
Novel Small Molecule Inhibitors Targeting the IL-6/STAT3 Pathway or IL-1β
Development of small molecules that inhibit inflammatory cytokines is a desirable strategy for the treatment of inflammatory diseases such as rheumatoid arthritis (RA). Following up a previous study, we synthesized 10 novel compounds with a 2,5-diaminobenzoxazole moiety and evaluated their biologica...
Autores principales: | Yoo, Jihye, Kim, Darong, Park, Jiyoung, Kim, Young-Kook, Park Choo, Hea-Young, Woo, Hyun Ae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101866/ https://www.ncbi.nlm.nih.gov/pubmed/35566047 http://dx.doi.org/10.3390/molecules27092696 |
Ejemplares similares
-
Novel Benzoxazoles Containing 4-Amino-Butanamide Moiety Inhibited LPS-Induced Inflammation by Modulating IL-6 or IL-1β mRNA Expression
por: Yoo, Jihye, et al.
Publicado: (2022) -
Induction of Unique STAT Heterodimers by IL-21 Provokes IL-1RI Expression on CD8(+) T Cells, Resulting in Enhanced IL-1β Dependent Effector Function
por: Kim, Dong Hyun, et al.
Publicado: (2021) -
Butein Inhibits Cell Growth by Blocking the IL-6/IL-6Rα Interaction in Human Ovarian Cancer and by Regulation of the IL-6/STAT3/FoxO3a Pathway
por: Park, Sun-Ae, et al.
Publicado: (2023) -
IL-13 and STAT6 signaling involve in low dose lipopolysaccharide induced murine model of asthma
por: Bang, Bo-Ram, et al.
Publicado: (2013) -
Genetic Association between Inflammatory-Related Polymorphism in STAT3, IL-1β, IL-6, TNF-α and Idiopathic Recurrent Implantation Failure
por: Kwon, Min Jung, et al.
Publicado: (2023)